← Leaderboards
Robert M Greenberg
University Of Florida
$7,228,512
Attributed
$7,523,679
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,523,679 · 10
By mechanism
R01$4,459,080 · 3
R21$3,064,599 · 7
Top collaborators
- Haim H Bau2 shared
- Changchun Liu2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Kendall Francis Morris$6,325,183
- Paul W Davenport$2,904,555
- Sandra L. Winkler$1,018,964
- Barbara K Smith$1,241,403
Others in their field
Top investigators on “Schistosomiasis”
- Jeffrey S Akman · George Washington University$15,000,000
- Edward J. Pearce · Cornell University Ithaca$11,346,993
- Jennifer F Friedman · Rhode Island Hospital$11,028,389
- Miguel J. Stadecker · Tufts University Boston$8,764,073
- James J Collins · Ut Southwestern Medical Center$8,321,594
- Brian Barkley Graham · University Of Colorado Denver$7,546,061
Research focus
SchistosomiasisSchistosoma MansoniAnthelminticsSchistosomaTropical DiseasePharmaceutical PreparationsTissuesHelminthsParasitesPlatyhelminthsPraziquantelPublishingMediatingResponseMolecularMemberGenomePlayDrug ResistanceProteinsPhysiologicalRna InterferencePropertyAffect
Grant awards (31)
Physiological roles of schistosome TRP ion channels with atypical pharmacology$402,500
R01 · FY2020 · AI · contact PI
Physiological roles of schistosome TRP ion channels with atypical pharmacology$402,500
R01 · FY2019 · AI · contact PI
Are schistosome micro-exon genes (MEGs) upregulated as an immune evasion response to the antischistosomal drug praziquantel?$201,250
R21 · FY2019 · AI · contact PI
Physiological roles of schistosome TRP ion channels with atypical pharmacology$402,500
R01 · FY2018 · AI · contact PI
Are schistosome micro-exon genes (MEGs) upregulated as an immune evasion response to the antischistosomal drug praziquantel?$241,500
R21 · FY2018 · AI · contact PI
Discovery of novel antiparasitics that target a pharmacologically atypical schistosome Transient Receptor Potential (TRP) ion channel$201,250
R21 · FY2018 · AI · contact PI
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings$201,250
R21 · FY2018 · AI · contact PI
Physiological roles of schistosome TRP ion channels with atypical pharmacology$402,500
R01 · FY2017 · AI · contact PI
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings$241,500
R21 · FY2017 · AI · contact PI
Discovery of novel antiparasitics that target a pharmacologically atypical schistosome Transient Receptor Potential (TRP) ion channel$241,500
R21 · FY2017 · AI · contact PI
A strategy for point-of-care molecular detection of parasitic helminth infections$200,000
R21 · FY2015 · AI · contact PI
A strategy for point-of-care molecular detection of parasitic helminth infections$240,000
R21 · FY2014 · AI · contact PI
Role of schistosome ABC transporters in modulation of host immune responses$200,000
R21 · FY2014 · AI · contact PI
Role of schistosome ABC transporters in modulation of host immune responses$240,000
R21 · FY2013 · AI · contact PI
Schistosome TRP ion channels as potential drug targets$225,600
R21 · FY2013 · AI · contact PI
Schistosome TRP ion channels as potential drug targets$200,000
R21 · FY2012 · AI · contact PI
Function and pharmacology of schistosome multidrug resistance proteins$344,166
R01 · FY2010 · AI · contact PI
Transformation of C. elegans with a novel schistosome calcium channel subunit$233,888
R21 · FY2010 · AI · contact PI
Function and pharmacology of schistosome multidrug resistance proteins$347,642
R01 · FY2009 · AI · contact PI
Transformation of C. elegans with a novel schistosome calcium channel subunit$196,861
R21 · FY2009 · AI · contact PI
Function and pharmacology of schistosome multidrug resistance proteins$347,642
R01 · FY2008 · AI · contact PI
Function and pharmacology of schistosome multidrug resistance proteins$187,033
R01 · FY2007 · AI · contact PI
Function and pharmacology of schistosome multidrug resistance proteins$167,661
R01 · FY2007 · AI · contact PI
Potential targets for new antischistosomal agents$183,093
R01 · FY2006 · AI · contact PI
Potential targets for new antischistosomal agents$48,184
R01 · FY2006 · AI · contact PI
Potential targets for new antischistosomal agents$238,500
R01 · FY2005 · AI
Potential targets for new antischistosomal agents$238,500
R01 · FY2004 · AI
Potential targets for new antischistosomal agents$217,500
R01 · FY2003 · AI
Potential targets for new antischistosomal agents$217,500
R01 · FY2002 · AI
POTENTIAL TARGETS FOR NEW ANTISCHISTOSOMAL AGENTS$158,133
R01 · FY2001 · AI
POTENTIAL TARGETS FOR NEW ANTISCHISTOSOMAL AGENTS$153,526
R01 · FY2000 · AI